Form 5500 Search
Back to filter
Original filing (PDF)20250702134147NAL0033132242001

ALS THERAPY DEVELOPMENT FOUNDATION

Form 5500-SF
FILING_RECEIVED
ALS THERAPY DEVELOPMENT FOUNDATION 403(B) PLAN
403(b) retirement plan
Active participants
50
Accounts w/ balance
86
Plan assets (EOY)
$8.9M
Net assets (EOY)
$8.9M
Plan health score (directional)
89
/ 100
Grade A
Top-tier plan health
Directional indicator computed from public Form 5500 data — compliance, concentration, cost, vendor stack and participation. Not a fiduciary tool.
Compliance & disclosures
100
Concentration risk
75
Total plan cost
75
Vendor stack
100
Participation health
100
Helping the score
  • Concentration not scored — Schedule of Assets PDF not yet parsed for this plan.
  • No Schedule C compensation disclosed — likely a small plan or unbundled.
Decision-maker contacts
CFO / Head of HR / Benefits Manager — verified email + LinkedIn for ALS THERAPY DEVELOPMENT FOUNDATION.
Plan sponsor
Name
ALS THERAPY DEVELOPMENT FOUNDATION
EIN
04-3462719
Address
480 ARSENAL WAY, SUITE 201 · WATERTOWN, MA · 02472
Phone
(617) 441-7200
Industry
Professional & Technical Servicessee all
Plan administrator
Same as plan sponsor.
Plan characteristics
Plan number
001
Plan year
2024
Plan year begin
2024-01-01
Tax period
2024-12-31
Filed
2025-07-02
Pension benefit codes
2F · ERISA section 404(c)
2G · Total participant-directed accounts
2L · 403(b)(1) annuity
2M · 403(b)(7) custodial accounts
2T · Default investment account (QDIA)
3D · Pre-approved plan (master / prototype / VS)
Audit & trust (Schedule H)
Auditor
Trustee / custodian
Trustee phone
Small plan (5500-SF) — Schedule H data not available.

Service providers (Schedule C)

Small plans don't disclose service providers

Related plans